Our identification of predominant expression of Csmd1 in adult brain may therefore indicate a relevance of the complement pathway in neuronal processes underlying the risk of schizophrenia, and may contribute to further insight into the suspected link between immunological factors and disease risk in psychiatric disorders. This evidence concerns the gene CSMD1 and schizophrenia.